Lung Cancer Screening Initiative in Slovakia: Guidelines of screening implementation

Area of Science:

• Oncology
• Public Health
• Radiology

Background:

• Lung cancer (LC) is a leading cause of cancer mortality globally, particularly in Slovakia and the European Union.
• Randomized controlled trials demonstrate a mortality benefit for LC patients undergoing screening with low-dose computed tomography (LDCT).
• European health authorities recommend national LC screening (LCS) programs.

Purpose of the Study:

• To outline the methodology, guidelines, and practical aspects of implementing LCS strategies in Slovakia.
• To detail principles for identifying asymptomatic high-risk individuals for LCS.
• To address the reduction of false positives, false negatives, and unnecessary invasive procedures within LCS programs.

Main Methods:

• Review of evidence supporting LDCT for lung cancer screening.
• Description of fundamental principles for LCS program implementation.
• Emphasis on quality standards for LDCT and resource utilization.

Main Results:

• Evidence supports LDCT screening for reducing lung cancer mortality.
• Key principles include accurate identification of high-risk individuals and minimizing procedural harms.
• Effective resource utilization and high-quality LDCT are critical for successful nationwide LCS.

Conclusions:

• National LCS programs are recommended based on demonstrated mortality benefits.
• Successful implementation requires careful methodology, adherence to guidelines, and quality control.
• Optimizing LCS programs can improve early detection and reduce lung cancer deaths.